Toxic shock-like syndrome and COVID-19: Multisystem inflammatory syndrome in children (MIS-C).


Journal

The American journal of emergency medicine
ISSN: 1532-8171
Titre abrégé: Am J Emerg Med
Pays: United States
ID NLM: 8309942

Informations de publication

Date de publication:
Nov 2020
Historique:
received: 26 05 2020
accepted: 31 05 2020
pubmed: 14 6 2020
medline: 18 12 2020
entrez: 14 6 2020
Statut: ppublish

Résumé

Early reports of COVID-19 in pediatric populations emphasized a mild course of disease with severe cases disproportionately affecting infant and comorbid pediatric patients. After the peak of the epidemic in New York City, in late April to early May, cases of severe illness associated with COVID-19 were reported among mostly previously healthy children ages 5-19. Many of these cases feature a toxic shock-like syndrome or Kawasaki-like syndrome in the setting of SARS-CoV-2 positive diagnostic testing and the CDC has termed this presentation Multisystem Inflammatory Syndrome (MIS-C). It is essential to disseminate information among the medical community regarding severe and atypical presentations of COVID-19 as prior knowledge can help communities with increasing caseloads prepare to quickly identify and treat these patients as they present in the emergency department. We describe a case of MIS-C in a child who presented to our Emergency Department (ED) twice and on the second visit was found to have signs of distributive shock, multi-organ injury and systemic inflammation associated with COVID-19. The case describes two ED visits by an 11- year-old SARS-CoV-2-positive female who initially presented with fever, rash and pharyngitis and returned within 48 hours with evidence of cardiac and renal dysfunction and fluid-refractory hypotension requiring vasopressors and PICU admission.

Identifiants

pubmed: 32532619
pii: S0735-6757(20)30492-7
doi: 10.1016/j.ajem.2020.05.117
pmc: PMC7274960
pii:
doi:

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

2492.e5-2492.e6

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Références

Indian Pediatr. 2020 Jul 15;57(7):681-683
pubmed: 32393681
Acta Paediatr. 2020 Jun;109(6):1088-1095
pubmed: 32202343
MMWR Morb Mortal Wkly Rep. 2020 Apr 10;69(14):422-426
pubmed: 32271728
Pediatrics. 2020 Jun;145(6):
pubmed: 32179660
N Engl J Med. 2020 Apr 23;382(17):1663-1665
pubmed: 32187458
Lancet Infect Dis. 2020 May;20(5):533-534
pubmed: 32087114
Lancet. 2020 Jun 6;395(10239):1771-1778
pubmed: 32410760
J Pediatr. 2020 Jul;222:261-262
pubmed: 32370951
Hosp Pediatr. 2020 Jun;10(6):537-540
pubmed: 32265235

Auteurs

Andrea G Greene (AG)

SUNY Downstate Health Sciences University, 450 Clarkson Ave., Brooklyn, NY 11203, USA. Electronic address: andrea.greene@downstate.edu.

Mona Saleh (M)

SUNY Downstate Health Sciences University, 450 Clarkson Ave., Brooklyn, NY 11203, USA. Electronic address: salehm3@nychhc.org.

Eric Roseman (E)

SUNY Downstate Health Sciences University, 450 Clarkson Ave., Brooklyn, NY 11203, USA.

Richard Sinert (R)

SUNY Downstate Health Sciences University, 450 Clarkson Ave., Brooklyn, NY 11203, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH